Skip to content

Category: Press Releases

Friends of Cancer Research Celebrates 20th Anniversary

Honors Dr. Janet Woodcock, Dr. Eric Lander, and Mr. Sean Parker for Contributions to Cancer Research Washington, DC, September 21, 2016 –  Friends of Cancer Research (Friends) will celebrate its 20th anniversary today at a special event in Washington DC. The event will honor Dr. Janet Woodcock, Dr. Eric Lander, and Mr. Sean Parker. During…

Friends' President and CEO Jeff Allen to Testify Before Congress

Allen Called Upon to Discuss LDT Use in Precision Medicine Washington, DC, September 20, 2016 – Today, Friends of Cancer Research (Friends) President & CEO, Jeff Allen, PhD, will testify at a Senate hearing on the use of laboratory developed tests (LDTs) in precision medicine. The hearing, held by the Health Education Labor and Pensions…

Cancer Moonshot Blue Ribbon Panel Presents Recommendations to National Cancer Advisory Board

Washington, DC – September 7, 2016 – Today the Cancer Moonshot Blue Ribbon Panel, comprised of 28 world-class leaders from science, research, and patient advocacy, including Friends of Cancer Research’s (Friends) Chair and Founder Ellen Sigal, presented their recommendations for accelerating cancer research to the President’s National Cancer Advisory Board. The Blue Ribbon Panel authored…

Friends' Executive Director, Jeff Allen, Named Organization's First Chief Executive Officer

Founder Ellen Sigal Stays as Board Chair, President Marlene Malek Becomes Vice Chair; New Leadership Structure Designed to Continue Success and Impact for Future Washington, DC, August 18, 2016 –  Friends of Cancer Research (Friends) announced today that Jeff Allen, PhD, will assume the role of President and CEO effective immediately. Friends’ founder, Ellen Sigal,…

VP Biden Holds Summit – Announces Pazdur as Acting Director of New FDA Oncology Center of Excellence

Washington, DC, June 29, 2016 –  Today, Vice President Biden is hosting the first National Cancer Moonshot Summit at Howard University. The event convenes hundreds of leaders across the health, academic, private industry, and philanthropic sectors to join together with patients, survivors, and advocates. The goal of the summit is to increase efforts and double…

Parker Institute to Progress Cancer Immunotherapy Research

Parker Institute to Progress Cancer Immunotherapy Research Friends Proud to be Launch Partner for Initiative                      Los Angeles, CA, April 13, 2016 –  Friends of Cancer Research (Friends) is proud to be a launch partner for the new Parker Institute. Announced today, the Institute was created through…

Dr. Ellen Sigal Appointed to Panel to Guide Vice President Biden's National Cancer Moonshot Initiative

Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates will inform the direction and goals of Moonshot                    Washington, DC, April 4, 2016 – Dr. Ellen Sigal, chairperson and founder of Friends of Cancer Research (Friends), has been appointed to the National Cancer Institute’s (NCI)…

Senate Puts Forth Legislation on FDA Centers of Excellence

Act Includes Friends of Cancer Research Proposal to Create Oncology Center of Excellence at FDA Washington, DC, March 17, 2016 – Friends of Cancer Research (Friends) would like to applaud Senator Alexander and Senator Murray for introducing the FDA and NIH Workforce Authorities Modernization Act. The Act takes several steps that will ultimately enhance cutting edge medical research. At a…

Greg Simon Named Executive Director for the White House's Cancer Moonshot Task Force

Washington, DC, March 18, 2016 – Friends of Cancer Research would like to congratulate Greg Simon on being named executive director of the White House’s Cancer Moonshot Task Force. Simon, a cancer survivor himself, co-founded FasterCures, an organization dedicated to saving lives by speeding up and improving medical research. Additionally, he has worked as the Senior…

Lung-MAP Precision Medicine Trial Makes Exciting Changes, With New Science and Treatment Options for Patients

Lung-MAP Precision Medicine Trial Makes Exciting Changes, With New Science and Treatment Options for Patients Lung-MAP, the most collaborative and comprehensive lung cancer clinical trial active in the U.S., uses a targeted screening approach to match patients with promising new cancer treatments based on their genomic profile. WASHINGTON, DC – The team behind the Lung…